Hospital Universitario Donostia

San Sebastián 20014

3 studies enrolling now · 12 studies all time

What they study most

Age Related Macular Degeneration, Atrial Fibrillation, Breast Cancer, Cardiac Arrhythmias, DM1, Dysferlinopathy, Endometrial Cancer, FSH Muscular Dystrophy, FSHD, FSHD - Facioscapulohumeral Muscular Dystrophy, FSHD1, FSHD2

Studies at this site

• Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects — Recruiting now
• A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD — Recruiting now
• Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) — Running, not enrolling
• Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer After Platinum-Based Chemotherapy and Immunotherapy (ASCENT-GYN-01/GOG-3104/ENGOT-en26) — Running, not enrolling
• Global Open-Label Extension Study of Del-desiran for the Treatment of DM1 — Enrolling by invitation
• PALbociclib CoLlaborative Adjuvant Study — Running, not enrolling
• Study BT8009-230 in Participants With Locally Advanced or Metastatic Urothelial Cancer (Duravelo-2) — Running, not enrolling
• Confirm Rx Insertable Cardiac Monitor SMART Registry — Completed
• Rostock International Parkinson's Disease Study (ROPAD) — Completed
• Tamibarotene Plus Azacitidine in Participants With Newly Diagnosed RARA-positive Higher-Risk Myelodysplastic Syndrome — Stopped early
• A Phase 3 Study to Compare the Efficacy and Safety of HLX04-O with Ranibizumab in Subjects with WAMD — Completed
• Clinical Outcome Study for Dysferlinopathy — Status unconfirmed